Evidence map›Paper›PMID 42825247›Full record

ArticleBMJ digital health & AI2026

From principles to practice: an actionable framework for AI governance in healthcare organisations.

Sam Freeman, Amy Wang, Sudeep Saraf, Erica Potts, Amy Mckimm, Enrico Coiera, Farah Magrabi

Abstract read
In one paragraph

Article in BMJ digital health & AI, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sam FreemanAustralian Institute of Health Innovation, Macquarie University, Sydney, New South Wales, Australia.
Amy WangAustralian Institute of Health Innovation, Macquarie University, Sydney, New South Wales, Australia.
Sudeep SarafAlfred Hospital, Melbourne, Victoria, Australia.
Erica PottsAlfred Hospital, Melbourne, Victoria, Australia.
Amy MckimmAlfred Hospital, Melbourne, Victoria, Australia.
Enrico CoieraAustralian Institute of Health Innovation, Macquarie University, Sydney, New South Wales, Australia.
Farah MagrabiAustralian Institute of Health Innovation, Macquarie University, Sydney, New South Wales, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Artificial intelligence (AI) technologies are being rapidly adopted in healthcare, yet organisational governance often lacks the processes needed to oversee their safe and responsible use. Previous AI governance frameworks largely focus on high-level AI ethics principles, leaving healthcare organisations struggling to translate these principles into practice, assess risk and embed AI oversight into existing processes. This study aimed to develop and validate a practice-oriented AI governance framework for healthcare organisations. Methods and analysis: We developed an AI governance framework using an exploratory multimethod design that drew on a scoping review, document analysis and semistructured interviews. The framework was validated through stakeholder workshops and application to three case studies of AI systems to identify patients for home-based care, radiology decision support and infection surveillance within a large tertiary healthcare organisation. The case studies represented real-world governance decisions faced by healthcare organisations and reflected the major pathways for acquiring AI capabilities: in-house development, commercial procurement and codevelopment with external partners. Results: The framework unifies ethics and governance principles, incorporates tiered oversight aligned with organisational digital maturity and includes a structured review checklist to support consistent decision-making about the implementation and operation of AI systems across clinical and operational contexts. Stakeholders found the framework relevant, usable and feasible to implement. Across the diverse AI use cases, the review checklist identified governance, safety and implementation risks and supported structured assessment and decision-making. The framework also enabled AI oversight to be integrated into existing organisational governance processes while supporting a proportionate approach to risk management across the AI life cycle. Conclusion: This study addresses an important gap between high-level AI governance principles and organisational implementation. The framework provides healthcare organisations with a structured approach to assessing, governing and monitoring AI systems throughout their life cycle and may support the safe and responsible adoption of AI in practice. Further research is needed to evaluate the framework across diverse healthcare settings and emerging AI technologies, including generative and agentic AI.

Indexed as

Artificial intelligenceClinical Governance

Identifiers

PMID42825247
PMCPMC13629979

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.